263 related articles for article (PubMed ID: 16978034)
1. Pharmacological treatments for thyroid eye disease.
Modjtahedi SP; Modjtahedi BS; Mansury AM; Selva D; Douglas RS; Goldberg RA; Leibovitch I
Drugs; 2006; 66(13):1685-700. PubMed ID: 16978034
[TBL] [Abstract][Full Text] [Related]
2. Efficacy and Safety of Immunosuppressive Agents for Thyroid Eye Disease.
Strianese D
Ophthalmic Plast Reconstr Surg; 2018; 34(4S Suppl 1):S56-S59. PubMed ID: 29923966
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of corticosteroids and external beam radiation in the management of moderate to severe thyroid eye disease.
Zoumalan CI; Cockerham KP; Turbin RE; Volpe NJ; Kazim M; Douglas RS; Feldon SE
J Neuroophthalmol; 2007 Sep; 27(3):205-14. PubMed ID: 17895822
[TBL] [Abstract][Full Text] [Related]
4. Corticosteroids in the medical treatment of thyroid ophthalmopathy: when and how? Somatostatin analogues: where we stand today.
Krassas GE; Gogakos A; Boboridis K
Pediatr Endocrinol Rev; 2010 Mar; 7 Suppl 2():204-9. PubMed ID: 20467364
[TBL] [Abstract][Full Text] [Related]
5. Treatment by rituximab on six Grave's ophthalmopathies resistant to corticosteroids.
Précausta F; Arsène S; Renoult-Pierre P; Laure B; Crinière L; Pisella PJ
Ann Endocrinol (Paris); 2017 Feb; 78(1):20-26. PubMed ID: 28185649
[TBL] [Abstract][Full Text] [Related]
6. Orbital Radiotherapy Combined With Corticosteroid Treatment for Thyroid Eye Disease-Compressive Optic Neuropathy.
Gold KG; Scofield S; Isaacson SR; Stewart MW; Kazim M
Ophthalmic Plast Reconstr Surg; 2018; 34(2):172-177. PubMed ID: 29517594
[TBL] [Abstract][Full Text] [Related]
7. Outcome of tocilizumab treatment in corticosteroid-resistant thyroid eye disease.
Pampín-Sánchez R; Martínez-Mugica-Barbosa C; Fonseca-Aizpuru EM; Barbazán-Vázquez FJ; Fernández-González B; Buznego-Súárez L
Med Clin (Barc); 2023 Feb; 160(3):113-117. PubMed ID: 36088128
[TBL] [Abstract][Full Text] [Related]
8. Reduced risk of compressive optic neuropathy using orbital radiotherapy in patients with active thyroid eye disease.
Shams PN; Ma R; Pickles T; Rootman J; Dolman PJ
Am J Ophthalmol; 2014 Jun; 157(6):1299-305. PubMed ID: 24582992
[TBL] [Abstract][Full Text] [Related]
9. Update on Graves disease: advances in treatment of mild, moderate and severe thyroid eye disease.
Strianese D
Curr Opin Ophthalmol; 2017 Sep; 28(5):505-513. PubMed ID: 28700384
[TBL] [Abstract][Full Text] [Related]
10. Adalimumab as steroid-sparing treatment of inflammatory-stage thyroid eye disease.
Ayabe R; Rootman DB; Hwang CJ; Ben-Artzi A; Goldberg R
Ophthalmic Plast Reconstr Surg; 2014; 30(5):415-9. PubMed ID: 24978425
[TBL] [Abstract][Full Text] [Related]
11. Ophthalmic complications in juvenile Graves' Disease - clinic and therapeutic approaches.
Krassas GE
Pediatr Endocrinol Rev; 2003 Dec; 1 Suppl 2():223-9; discussion 229. PubMed ID: 16444162
[TBL] [Abstract][Full Text] [Related]
12. Compressive Optic Neuropathy in Thyroid Eye Disease.
Thyparampil P; Yen MT
Int Ophthalmol Clin; 2016; 56(1):51-67. PubMed ID: 26626932
[No Abstract] [Full Text] [Related]
13. Medical treatment in thyroid eye disease in 2020.
Khong JJ; McNab A
Br J Ophthalmol; 2021 Mar; 105(3):299-305. PubMed ID: 32447327
[TBL] [Abstract][Full Text] [Related]
14. The Role of Biological Agents and Immunomodulators in Treatment Strategies for Thyroid Eye Disease: An Evidence-based Review.
Ginter A; Migliori ME
R I Med J (2013); 2016 Jun; 99(6):26-9. PubMed ID: 27247969
[TBL] [Abstract][Full Text] [Related]
15. Viral conjunctivitis interfering with the clinical activity score and management of thyroid ophthalmopathy.
Boboridis KG; Konstas AG; Krassas GE; Georgiadis NS
Orbit; 2006 Mar; 25(1):27-9. PubMed ID: 16527772
[TBL] [Abstract][Full Text] [Related]
16. Radiotherapy for Active Thyroid Eye Disease.
Godfrey KJ; Kazim M
Ophthalmic Plast Reconstr Surg; 2018; 34(4S Suppl 1):S98-S104. PubMed ID: 29771752
[TBL] [Abstract][Full Text] [Related]
17. Advances in the management of thyroid eye diseases: An overview.
Kumari R; Chandra Saha B
Int Ophthalmol; 2018 Oct; 38(5):2247-2255. PubMed ID: 28822031
[TBL] [Abstract][Full Text] [Related]
18. Management of thyroid eye disease.
Bartalena L; Marcocci C; Tanda L; Pinchera A
Eur J Nucl Med Mol Imaging; 2002 Aug; 29 Suppl 2():S458-65. PubMed ID: 12192546
[TBL] [Abstract][Full Text] [Related]
19. Failure of rituximab treatment in a case of severe thyroid ophthalmopathy unresponsive to steroids.
Krassas GE; Stafilidou A; Boboridis KG
Clin Endocrinol (Oxf); 2010 Jun; 72(6):853-5. PubMed ID: 20039891
[No Abstract] [Full Text] [Related]
20. Update on the clinical assessment and management of thyroid eye disease.
Roos JCP; Murthy R
Curr Opin Ophthalmol; 2019 Sep; 30(5):401-406. PubMed ID: 31313753
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
